Improving patient outcomes: role of the primary care optometrist in the early diagnosis and management of age-related macular degeneration

References

• Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011;129(1):75–80.
   PubMedGoogle Scholar
• Congdon N, O’Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485.
   PubMed Web of Science ®Google Scholar
• Access Economics. The Global Economic Cost of Visual Impairment. Canberra, Sydney, and Melborne: Access Economics; 2010. Available from: http://www.amdalliance.org/user_files/documents/Global%20 cost%20of%20VI_FINAL%20report.pdf. Accessed August 29, 2012.
   Google Scholar
• Alliance for Aging Research. The Silver Book: Vision Loss. Washington, DC: Alliance for Aging Research; 2012.
   Google Scholar
• Day S, Acquah K, Lee PP, Mruthyunjaya P, Sloan FA. Medicare costs for neovascular age-related macular degeneration,1994–2007. Am J Ophthalmol. 2011;152(6):1014–1020.
   PubMed Web of Science ®Google Scholar
• Cruess AF, Zlateva G, Xu X, et al. Economic burden of bilateral neo- vascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics. 2008;26(1):57–73.
   PubMed Web of Science ®Google Scholar
• Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med. 2000;342(7):483–492.
   PubMed Web of Science ®Google Scholar
• American Optometric Association. Care of the Patien t with Age-Related Macular Degeneration: Reference Guide for Clinicians. Optometric Clinical Practice Guideline. St Louis, MO: American Optometric Association; 2004. Available from: http://www.aoa.org/documents/ CPG-6.pdf. Accessed October 25, 2012.
   Google Scholar
• Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and metaanalysis. BMC Ophthalmol. 2010;10:31.
   PubMed Web of Science ®Google Scholar
• Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet. 2009;10:19–43.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Augood C, Bentham GC, et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology. 2007;114(6):1157–1163.
   PubMed Web of Science ®Google Scholar
• Tomany SC, Klein R, Klein BE; Beaver Dam Eye Study. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110(8):1526–1533.
   Web of Science ®Google Scholar
• Lavanya R, Kawasaki R, Tay WT, et al. Hyperopic refractive error and shorter axial length are associated with age-related macular degeneration: the Singapore Malay Eye Study Invest Ophthalmol Vis Sci. 2010;51(12):6247–6252.
   Web of Science ®Google Scholar
• Liu C, Maguire M, Ying GS; CAPT Research Group. Refractive error in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): risk of late AMD and 5-year changes. Invest Ophthalmol Vis Sci. 2007;48:E-Abstract 2090.
   Google Scholar
• Hogg RE, Woodside JV, Gilchrist SE, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology. 2008;115(6):1046–1052. e2.
   Web of Science ®Google Scholar
• Topouzis F, Anastasopoulos E, Augood C, et al. Association of diabetes with age-related macular degeneration in the EUREYE study. Br J Ophthalmol. 2009;93(8):1037–1041.
   Web of Science ®Google Scholar
• Neuner B, Komm A, Wellmann J, et al. Smoking history and the incidence of age-related macular degeneration – results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav. 2009;34(11):938–947.
   PubMed Web of Science ®Google Scholar
• Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol. 2001;119(2):246–250.
   Google Scholar
• Fletcher AE, Bentham GC, Agnew M, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126(10):1396–1403.
   Google Scholar
• Jia L, Shen X, Fan R, et al. Risk factors for age-related macular degeneration in elderly Chinese population in Shenyang of China. Biomed Environ Sci. 2011;24(5):506–511.
   Web of Science ®Google Scholar
• Mares JA, Voland RP, Sondel SA, et al. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol. 2011;129(4):470–480.
   PubMed Web of Science ®Google Scholar
• Williams PT. Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci. 2009;50(1):101–106.
   Web of Science ®Google Scholar
• Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol. 1994;112(4):500–509.
   Google Scholar
• Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database SystRev. 2007;3:CD002030.
   Web of Science ®Google Scholar
• Schlingemann RO, Witmer AN. Treatment of retinal diseases with VEGF antagonists. Prog Brain Res. 2009;175:253–267.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Korobelnik JF, Lanzetta P, et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol. 2010;94(1):2–13.
   PubMed Web of Science ®Google Scholar
• Martin DF, Maguire MG, Fine SL, et al; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Ranibizumab and bevacizumab for treatment of neovascular age- related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388–1398.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no 8. Arch Ophthalmol. 2001;119(10):1417–1436.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Age-Related Eye Disease Study 2 Protocol: Age-Related Eye Disease Study 2 (AREDS2): Available from: https://web.emmes.com/study/areds2/resources/ areds2_protocol.pdf. Accessed August 2, 2012.
   Google Scholar
• SanGiovanni JP, Chew EY, Clemons TE, et al; Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report no 22. Arch Ophthalmol. 2007;125(9):1225–1232.
   PubMedGoogle Scholar
• Ma L, Dou HL, Wu YQ, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br JNutr. 2012;107(3):350–359.
   PubMed Web of Science ®Google Scholar
• Bartlett H, Eperjesi F. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthalmic Physiol Opt. 2005;25(3):179–194.
   Web of Science ®Google Scholar
• Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2012;6:CD000253.
   Web of Science ®Google Scholar
• Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44(10):4481–4488.
   PubMed Web of Science ®Google Scholar
• Liu L, White J. Early age-related macular degeneration impairs tolerance to stimulus degradation. Optom Vis Sci. 2010;87(8):532–542.
   Web of Science ®Google Scholar
• Arias L, Armadá F, Donate J, et al. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye (Lond). 2009;23(2):326–333.
   Web of Science ®Google Scholar
• Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology. 2006;113(11):1974–1986.
   Web of Science ®Google Scholar
• Patty L, Wu C, Torres M, Azen S, Varma R; Los Angeles Latino Eye Study Group. Validity of Self-reported Eye Disease and Treatment in a Population-based Study: The Los Angeles Latino Eye Study. Ophthalmology. 2012;119(9):1725–1730.
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D. Neovascular age-related macular degeneration: Natural History and Treatment Outcomes. Retina. 2005;25(8):1065–1084.
   PubMed Web of Science ®Google Scholar
• Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev. 2006;3:CD001054.
   Web of Science ®Google Scholar
• Chou R, Dana T, Bougatsos C. Screening older adults for impaired visual acuity: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2009;151(1):44–58, W11–20.
   Web of Science ®Google Scholar
• Hanson C, Tennant MT, Rudnisky CJ. Optometric referrals to retina specialists: evaluation and triage via teleophthalmology. Telemed JE Heath. 2008;14(5):441–445.
   Web of Science ®Google Scholar
• Kelly SP, Wallwork I, Haider D, Qureshi K. Teleophthalmology with optical coherence tomography imaging in community optometry. Evaluation of a quality improvement for macular patients. Clin Ophthalmol. 2011;5:1673–1678.
   PubMedGoogle Scholar
• American Academy of Ophthalmology Retina Panel. Preferred Practice Guidelines®. Age-Related Macular Degeneration. San Francisco, CA: American Academy of Ophthalmology; 2008. Available from: http://one.aao.org/asset.axd?id=b1f95ead-7fd4–49e7-bcc9-b12249916069. Accessed October 26, 2012.
   Google Scholar
• Myers RI. Interprofessional strategies for optometry and ophthalmology in the future. Optom Vis Sci. 1995;72(1):42–44.
   Web of Science ®Google Scholar
• Banes MJ, Culham LE, Bunce C, Xing W, Viswanathan A, Garway- Heath D. Agreement between optometrists and ophthalmologists on clinical management decisions for patients with glaucoma. Br J Ophthalmol. 2006;90(5):579–585.
   Web of Science ®Google Scholar
• O’Connor PM, Harper CA, Brunton CL, Clews SJ, Haymes SA, Keeffe JE. Shared care for chronic eye diseases: perspectives of ophthalmologists, optometrists and patients. Med JAust. 2012;196(10):646–650.
   Google Scholar
• Attebo K, Ivers RQ, Mitchell P. Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology. 1999;106(6):1066–1072.
   PubMed Web of Science ®Google Scholar
• Davey CJ, Green C, Elliott DB. Assessment of referrals to the hospital eye service by optometrists and GPs in Bradford and Airedale. Ophthalmic Physiol Opt. 2011;31(1):23–28.
   Web of Science ®Google Scholar
• Edlow RC, Marcus GR. Highlights: 2008 American Optometric Association Scope of Practice Survey. Optometry. 2009;80(5):267–270.
   Google Scholar
• Goujon N, Brown CM, Xie J, et al. Self-reported vision and health of indigenous Australians. Clin Experiment Ophthalmol. 2010;38(8):796–804.
   Web of Science ®Google Scholar
• Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50(5):2044–2053.
   PubMed Web of Science ®Google Scholar
• Stone EM, Aldave AJ, Drack AV, et al. Recommendations for Genetic Testing of Inherited Eye Diseases: Report of the American Academy of Ophthalmology Task Force on Genetic Testing. Ophthalmology. Nov 2012;119(11):2408–2410.
   PubMed Web of Science ®Google Scholar
• Hogg RE, Chakravarthy U. Vi sual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res. 2006;25(3):249–276.
   PubMed Web of Science ®Google Scholar
• Lovie-Kitchin J, Feigl B. Assessment of age-related maculopathy using subjective vision tests. Clin Exp Optom. 2005;88(5):292–303.
   Google Scholar
• Dimitrov PN, Robman LD, Varsamidis M, et al. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(13):9457–9469.
   PubMed Web of Science ®Google Scholar
• de Kinkelder R, van Leeuwen TG, Verbraak FD. Detection of early- stage age related macular degeneration with a compact rarebit test. Br J Ophthalmol. 2012;96(10):1354–1355.
   Web of Science ®Google Scholar
• Wang YZ, Wilson E, Locke KG, Edwards AO. Shape discrimination in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2002;43(6):2055–2062.
   Web of Science ®Google Scholar
• Bedell HE, Tong J, Woo SY, House JR, Nguyen T. Orientation discrimination with macular changes associated with early AMD. Optom Vis Sci. 2009;86(5):485–491.
   Web of Science ®Google Scholar
• Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ. 1995;311(7013):1131–1135.
   Google Scholar
• Creer R, Parkes J, Charles S, Harper R. Optometric management of age-related macular degeneration: referral and referral refinement pilot surveys. Optometry in Practice. 2010;11(1):13–25.
   Google Scholar
• Loughman J. Online AMD research study for optometrists: current practice in the Republic of Ireland and UK. Optometry in Practice. 2011;12(4):135–144.
   Google Scholar
• Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res. 2010;50(7):716–728.
   Web of Science ®Google Scholar
• Nutrition counseling in the optometric practice. Optometry. 2009;80(10):587–589.
   Google Scholar
• Spaide RF. Autofluorescence imaging with the fundus camera. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, editors. Atlas of Fundus Autofluorescence Imaging. Berlin and Heidelberg: Springer; 2007:49–53.
   Google Scholar
• Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol. 2009;54(1):96–117.
   PubMed Web of Science ®Google Scholar
• Padnick-Silver L, Weinberg AB, Lafranco FP, Macsai MS. Pilot study for the detection of early exudative age-related macular degeneration with optical coherence tomography. Retina. 2012;32(6):1045–1056.
   Web of Science ®Google Scholar
• Whatham AR, Pye D. Imaging into the future of optometric practice. Clin Exp Optom. 2008;91(6):501–503.
   Web of Science ®Google Scholar
• Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology. 2004;111(2):250–255.
   PubMed Web of Science ®Google Scholar
• Scott IU. Early detection of choroidal neovascularization: a new paradigm in the management of AMD. Paper presented at the Annual Meeting of the American Academy of Ophthalmology. October 15–18, 2005; Chicago, IL.
   Google Scholar
• Crossland M, Rubin G. The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol. 2007;91(3):391–393.
   Web of Science ®Google Scholar
• Loewenstein A, Malach R, Goldstein M, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology. 2003;110(5):966–970.
   Web of Science ®Google Scholar
• Alster Y, Bressler NM, Bressler SB, et al; Preferential Hyperacuity Perimetry Research Group. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology. 2005;112(10):1758–1765.
   PubMed Web of Science ®Google Scholar
• Loewenstein A, Ferencz JR, Lang Y, et al. Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device. Retina. Jul-Aug 2010;30(7):1058–1064.
   PubMed Web of Science ®Google Scholar
• College of Optometrists. Framework for Optometric Referrals. London: College of Optometrists; March, 2010.
   Google Scholar
• Muen WJ, Hewick SA. Quality of optometry referrals to neovascular age-related macular degeneration clinic: a prospective study. JRSM Short Rep. 2011;2(8):64.
   Google Scholar
• Prasad S, Kamath GG, Jones K, Clearkin LG, Phillips RP Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicroscopy. Eye (Lond). 2001;15(Pt 5):595–601.
   Google Scholar
• Arbuthnot T. PEARS scheme in Wales: results of a practice self-audit. Optometry Today. November 4, 2005;22–24.
   Google Scholar
• Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 2009;148(1):43–58. e1.
   PubMed Web of Science ®Google Scholar
• Manousaridis K, Manjunath V, Talks J. Information used to decide on retreatment of exudative age-related macular degeneration with anti-VEGF in clinical practice. Eur J Ophthalmol. 2013;23(1):3.
   Web of Science ®Google Scholar
• AMD Alliance International. Awareness of Age-Related Macular Degeneration and Associated Risk Factors: AMD Global Report 2005. Toronto: AMD Alliance International; 2005. Available from: http://www.amdalliance.org/user_files/documents/Global_Report_Aug22. doc. Accessed October 26, 2012.
   Google Scholar
• Noertjojo K, Maberley D, Bassett K, Courtright P. Awareness of eye diseases and risk factors: identifying needs for health education and promotion in Canada. Can J Ophthalmol. 2006;41(5):617–623.
   PubMed Web of Science ®Google Scholar
• Handa S, Woo JH, Wagle AM, Htoon HM, Au Eong KG. Awareness of blindness and other smoking-related diseases and its impact on motivation for smoking cessation in eye patients. Eye (Lond). 2011;25(9):1170–1176.
   Web of Science ®Google Scholar
• Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2012–2022.
   PubMed Web of Science ®Google Scholar
• Thompson C, Harrison RA, Wilkinson SC, Scott-Samuel A, Hemmerdinger C, Kelly SP. Attitudes of community optometrists to smoking cessation: an untapped opportunity overlooked? Ophthalmic Physiol Opt. 2007;27(4):389–393.
   Web of Science ®Google Scholar
• Brûlé J, Abboud C, Deschambault E. Smoking cessation counselling practices among Québec optometrists: evaluating beliefs, practices, barriers and needs. Clin Exp Optom. 2012;95(6):599–605.
   Web of Science ®Google Scholar
• Kennedy RD, Spafford MM, Schultz AS, Iley MD, Zawada V Smoking cessation referrals in optometric practice: a Canadian pilot study. Optom Vis Sci. 2011;88(6):766–771.
   Web of Science ®Google Scholar
• Gordon JS, Andrews JA, Lichtenstein E, Severson HH, Akers L, Williams C. Ophthalmologists’ and optometrists’ attitudes and behaviours regarding tobacco cessation intervention. Tob Control. 2002;11(1):84–85.
   Web of Science ®Google Scholar
• Spafford MM, Iley MD, Schultz AS, Kennedy RD. Tobacco dependence education in optometry: a Canadian pilot study assessing practices and opportunities. Optom Educ. 2010;36(1):38–44.
   Google Scholar
• Centers for Medicare and Medicaid Services. 2011 Physician Quality Reporting System Measure Specifications Manual for Claims and Registry Reporting of Individual Measures. 2011. Available from: http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment- Instruments/PQRS/downloads/2011_PhysQualRptg_MeasureSpecifica- tionsManual_033111.pdf. Accessed October 11, 2012.
   Google Scholar
• Sheck LH, Field AP, McRobbie H, Wilson GA. Helping patients to quit smoking in the busy optometric practice. Clin Exp Optom. 2009;92(2):75–77.
   Web of Science ®Google Scholar
• US Department of Agriculture, US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington DC: US Government Printing Office; 2010.
   Google Scholar
• [No authors listed]. What eye care patients should know about nutrition. Optometry. 2009;80(10):590–591.
   Google Scholar
• Elliott JG, Williams NS. Nutrients in the battle against age-related eye diseases. Optometry. 2012;83(1):47–55.
   Google Scholar
• Krishnadev N, Meleth AD, Chew EY. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol. 2010;21(3):184–189.
   Web of Science ®Google Scholar
• Raniga A, Elder MJ. Dietary supplement use in the prevention of age- related macular degeneration progression. NZMed J. 2009;122(1299):32–38.
   Google Scholar
• Anshel JR, Gerson JD, Capogna L, Richer SP, Shechtman DL. New paradigms in the understanding and management of ocular nutrition. Review of Optometry. Available at http://www.revoptom.com/supple- ment_toc/s/201/. Accessed 9 November, 2012.
   Google Scholar
• Larson T, Coker J. A descriptive study of lutein and zeaxanthin in optometric practice. Optometry. 2009;80(10):579–586.
   Google Scholar
• Glazer-Hockstein C, Dunaief JL. Could blue light-blocking lenses decrease the risk of age-related macular degeneration? Retina. 2006;26(1):1–4.
   Web of Science ®Google Scholar
• Mainster MA, Turner PL. Blue-blocking IOLs decrease photoreception without providing significant photoprotection. Surv Ophthalmol. 2010;55(3):272–289.
   PubMed Web of Science ®Google Scholar
• Roberts JE. Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye Contact Lens. 2011;37(4):246–249.
   PubMed Web of Science ®Google Scholar
• Information on nutrition and eye health. Optometry. 2009;80(10):599–601.
   Google Scholar
• Bureau of Labor Statistics. Optometrists. In: Occupational outlook handbook: healthcare [web page on the Internet]. 2012–2013 ed. Washington DC: Bureau of Labor Statistics; 2012. http://www.bls. gov/ooh/Healthcare/Optometrists.htm. Accessed August 6, 2012.
   Google Scholar
• Resnikoff S, Felch W, Gauthier TM, Spivey B. The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners. Br J Ophthalmol. 2012;96(6):783–787.
   PubMed Web of Science ®Google Scholar
• National Statistics, National Health Service Health and Social Care Information Centre. General Ophthalmic Services: Workforce Statistics for England and Wales. Leeds: National Health Service Health and Social Care Information Centre; 2012. Available from: http://www.ic.nhs.uk/webfiles/publications/007_Primary_Care/Eye_care/ General_0phthalmic_Services_Wkforce_31DEC2011/GOS_Work force_Stats_Eng_Wal_31Dec11_Report.pdf. Accessed August 8, 2012.
   Google Scholar
• Australian Institute of Health and Welfare. Eye Health Labour Force in Australia. Canberra: Australian Institute of Health and Welfare; 2009.
   Google Scholar
• Canadian Institute for Health Information. Canada’s Health Care Providers, 2000 to 2009: A Reference Guide. Ottawa: Canadian Institute for Health Information; 2011.
   Google Scholar